Stryker Mako Orthopedic Surgical Robotics
by Nick Clark | Published April 25, 2026
Stryker Mako operates the dominant orthopedic surgical-robotics platform with over 1.5 million procedures performed. Architectural element — stage-gated commitment with reversibility-aware execution — is what governed actuation provides for emerging autonomy.
Mako Reality
Stryker Mako operates orthopedic surgical-robotics platform across knee replacement, hip replacement, and emerging spinal applications. Deployment scale and procedure volume are substantial.
Path Toward Autonomous Phases
Mako currently operates as surgeon-controlled bone-resection robotics; emerging autonomous-phase operations face structural regulatory engagement (FDA PCCP). Stage-gated commitment provides structurally-supported autonomy substrate.
Architectural Fit
Each surgical sub-phase admits through composite admissibility; reversibility classification (bone resection is irreversible) drives stage-gated authority.
Stryker Position
Stryker gains FDA-aligned architectural substrate ahead of pure-platform-replacement competitive pressure.
